McCann Health expanded its executive team with three significant appointments. Marcus Sigurdsson was named to the new position of global chief digital officer. Linda Szyper was appointed to the new position of global chief operating officer. June Laffey was named to the new position of executive VP, chief creative officer, McCann Health New York.
The names of the tools may be changing, but the goal for brand managers remains the same in 2018: getting as close as possible to real patients and their needs.
Med Ad News asked its sources what are some of the key industry trends for 2018.
It’s not a new trend. For years, there has been massive speculation on the many ways Amazon could be getting into healthcare. But if you look past the hype, beyond Amazon’s theoretical intentions, and focus more closely on today’s consumer, there is a colossal healthcare trend underway even without Amazon getting in on the game. One can learn a lot from the trend of Amazon’s influence on the business of doing business. So let’s take a closer look …
According to the consultants at PwC, the top health industry issues of 2018 will be …
Deal activity is rampant as Big Pharma gobbles up next-generation medicines and technologies to help overcome maturing pipelines and biosimilar threats.
As more innovative – yet even more expensive – therapies enter the U.S. market, brand marketers will have to find equally new and innovative ways to prove the value of their medicines to payers and patients, especially as insurance plans continue to put more of the cost burden on patients.
On Oct. 28, 2016, my mother, Joan Biamonte, died of complications from metastatic carcinoma of the lung. Despite having her original tumor characterized and going through a regimen of chemotherapy allegedly tailored to her tumor type, her cancer proliferated and spread into her liver and brain.
Robert Leverte Jr. was honored by the Medical Advertising Hall of Fame as its 2018 inductee on February 8 at a black-tie event at The Pierre Hotel in New York City. Leverte’s prolific career has included founding ERS – an in-house ad agency at ER Squibb – co-founding Ruvane-Leverte advertising, serving as chairman at Bozell Jacobs Medical Group, and operating as CEO of the Leverte Companies.
Publicis Health promoted Alexandra von Plato to the role of CEO and Michael du Toit was named chief growth officer.
Jennifer Gottlieb was appointed president of W2O Group, a network of complementary analytics and insights-driven, digital marketing communications firms. In this newly created role, Gottlieb has responsibility for three operating companies – W2O wcg, W2O twist, and W2O pure. Gottlieb continues to report to founder and CEO Jim Weiss, who retains responsibility for overall firm strategy and operations globally as well as business development, innovation, and marketing.
Diane Iler-Smith returned to Biolumina as senior VP, executive creative director. Iler-Smith has more than 20 years of strategic and creative leadership experience in healthcare communications, including extensive global and US branding and launch expertise. She leads all creative assignments at the agency.
Intouch Solutions continues to elevate employees across the agency.
I recently read an article about how awards do not really matter in the advertising industry. The author basically said the only thing advertising is supposed to do is sell stuff. I agree, but not completely. Awards do matter.
So what is leadership? I believe leadership consists of three components: commitment, integrity, and respect.
The U.S. regulatory landscape will continue to evolve in 2018, potentially adding complexity and compliance challenges to the life sciences industry. Recent changes are being driven by nationwide concerns with prescription drug abuse, which is prompting many states to enforce new mandates and programs regarding drug practices.
Two thirds, or 67 percent, of respondents have encountered lower turnover from direct hire sales reps as opposed to CSO reps, according to a recent survey of executives by Best Practices LLC.
As the landscape for pharmaceutical marketing continues to evolve, multi-channel marketers have been investigating opportunities to advertise their products and services, and provide clinical decision support information within electronic health records (EHRs). For the first time, healthcare marketers can impact provider-patient interactions by delivering messages directly at the point of care. EHRs have over 90 percent adoption with healthcare professionals (HCPs) in the U.S., while certain practice specialties reach nearly ubiquitous (99 percent) adoption, thereby creating an exceptional opportunity not to be missed!